1.32
+0.02(+1.54%)
Currency In USD
| Previous Close | 1.3 |
| Open | 1.3 |
| Day High | 1.39 |
| Day Low | 1.3 |
| 52-Week High | 3.42 |
| 52-Week Low | 0.93 |
| Volume | 530,014 |
| Average Volume | 555,778 |
| Market Cap | 65.94M |
| PE | -1.38 |
| EPS | -0.96 |
| Moving Average 50 Days | 1.2 |
| Moving Average 200 Days | 2.07 |
| Change | 0.02 |
If you invested $1000 in Akoya Biosciences, Inc. (AKYA) since IPO date, it would be worth $50.67 as of July 02, 2025 at a share price of $1.32. Whereas If you bought $1000 worth of Akoya Biosciences, Inc. (AKYA) shares 3 years ago, it would be worth $100.76 as of July 02, 2025 at a share price of $1.32.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
GlobeNewswire Inc.
Apr 24, 2025 12:00 PM GMT
ADC assay now available through ABS; customer study proves IO60 is a spatial workhorseMARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, today announced the availability of a
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas
GlobeNewswire Inc.
Apr 24, 2025 12:00 PM GMT
>8,500 samples and 100 million cells of high resolution and fully annotated spatial proteomics data availableMARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Enable Med
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore
GlobeNewswire Inc.
Apr 23, 2025 12:00 PM GMT
The STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study is a multi-institutional study led by STCC with the goal of identifying predictors of PD1 immunotherapy response in an Asian real-world setting, bringing together Singapore’s public healt